Mechanisms of convulsions in eclampsia

Medical Hypotheses

Volumn 72, Issue 1, 2009, Pages 49-51

  Wasseff, Sameh ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; ENDOTHELIN; MAGNESIUM SULFATE; NEUROKININ B; NIMODIPINE; PROTEIN ENDOLGIN; PROTEIN SFLT1; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ARTICLE; BRAIN EDEMA; BRAIN VASOSPASM; CELL SURVIVAL; CONVULSION; ECLAMPSIA; EPILEPSY; EXCITABILITY; HUMAN; HYPERTENSION ENCEPHALOPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

CYTOKINES; ECLAMPSIA; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; NEUROKININ B; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PROTEINURIA; SEIZURES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 56249111927     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2008.08.017     Document Type: Article

References (50)

1. Venkatesha S., Toporsian M., Lam C., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12 (2006) 642-649
2. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
3. Reynolds C., Mabie W.C., and Sibai B.M. Hypertensive states of pregnancy. In: DeCherney A.H., and Nathan L. (Eds). Current obstetric & gynecologic diagnosis and treatment (2002), McGraw-Hill, New York
4. Chang J., Elam-Evans L.D., Berg C.J., et al. Pregnancy-related mortality surveillance - United States, 1991-1999. MMWR Surveill Summ 52 (2003) 1-8
5. Cunningham F.G., and Williams J.W. Williams obstetrics (2001), McGraw-Hill, New York
6. Belfort M.A., Giannina G., and Herd J.A. Transcranial and orbital Doppler ultrasound in normal pregnancy and preeclampsia. Clin Obstet Gynecol 42 (1999) 479-506
7. Belfort M.A., Grunewald C., Saade G.R., Varner M., and Nisell H. Preeclampsia may cause both overperfusion and underperfusion of the brain: a cerebral perfusion based model. Acta Obstet Gynecol Scand 78 (1999) 586-591
8. Belfort M.A., Saade G.R., Grunewald C., et al. Association of cerebral perfusion pressure with headache in women with pre-eclampsia. Brit J Obstet Gynecol 106 (1999) 814-821
9. Belfort M.A., Saade G.R., Yared M., et al. Change in estimated cerebral perfusion pressure after treatment with nimodipine or magnesium sulfate in patients with preeclampsia. Am J Obstet Gynecol 181 (1999) 402-407
10. Zeeman G.G., Fleckenstein J.L., Twickler D.M., and Cunningham F.G. Cerebral infarction in eclampsia. Am J Obstet Gynecol 190 (2004) 714-720
11. Loureiro R., Leite C.C., Kahhale S., et al. Diffusion imaging may predict reversible brain lesions in eclampsia and severe preeclampsia: initial experience. Am J Obstet Gynecol 189 (2003) 1350-1355
12. Kaplan P.W. Neurologic aspects of eclampsia. Neurol Clin 22 (2004) 841-861
13. Cunningham F.G., and Twickler D. Cerebral edema complicating eclampsia. Am J Obstet Gynecol 182 (2000) 94-100
14. Chen J.W., Naylor D.E., and Wasterlain C.G. Advances in the pathophysiology of status epilepticus. Acta Neurol Scand 115 (2007) 7-15
15. Morriss M.C., Twickler D.M., Hatab M.R., Clarke G.D., Peshock R.M., and Cunningham F.G. Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe preeclampsia. Obstet Gynecol 89 (1997) 561-568
16. Zeeman G.G., Hatab M.R., and Twickler D.M. Increased cerebral blood flow in preeclampsia with magnetic resonance imaging. Am J Obstet Gynecol 191 (2004) 1425-1429
17. Belfort M.A., Anthony J., Saade G.R., and Allen Jr. J.C. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. New Engl J Med 348 (2003) 304-311
18. Page N.M., Woods R.J., Gardiner S.M., et al. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature 405 (2000) 797-800
19. D'Orleans-Juste P., Claing A., Telemaque S., Warner T.D., and Regoli D. Neurokinins produce selective venoconstriction via NK-3 receptors in the rat mesenteric vascular bed. Eur J Pharmacol 204 (1991) 329-334
20. Baumann H., and Huch R. Maternal hemodynamics in pregnancy. Am J Obstet Gynecol 165 (1991) 237-238
21. D'Anna R., Baviera G., Corrado F., et al. Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction. Bjog 111 (2004) 1046-1050
22. Lecci A., and Maggi C.A. Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases. Exp Opin Therap Targets 7 (2003) 343-362
23. Wasterlain C.G., Mazarati A.M., Naylor D., et al. Short-term plasticity of hippocampal neuropeptides and neuronal circuitry in experimental status epilepticus. Epilepsia 43 Suppl. 5 (2002) 20-29
24. Maubach K.A., Cody C., and Jones R.S. Tachykinins may modify spontaneous epileptiform activity in the rat entorhinal cortex in vitro by activating GABAergic inhibition. Neuroscience 83 (1998) 1047-1062
25. Marksteiner J., Wahler R., Bellmann R., Ortler M., Krause J.E., and Sperk G. Limbic seizures cause pronounced changes in the expression of neurokinin B in the hippocampus of the rat. Neuroscience 49 (1992) 383-395
26. Schwarzer C., Williamson J.M., Lothman E.W., Vezzani A., and Sperk G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience 69 (1995) 831-845
27. Stanimirovic D.B., Bacic F., Uematsu S., and Spatz M. Profile of prostaglandins induced by endothelin-1 in human brain capillary endothelium. Neurochem Int 23 (1993) 385-393
28. Sagsoz N., and Kucukozkan T. The effect of treatment on endothelin-1 concentration and mean arterial pressure in preeclampsia and eclampsia. Hypertens Pregnancy 22 (2003) 185-191
29. Gross P.M., and Weaver D.F. A new experimental model of epilepsy based on the intraventricular injection of endothelin. J Cardiovasc Pharmacol 22 Suppl. 8 (1993) S282-S287
30. Clark B.A., Halvorson L., Sachs B., and Epstein F.H. Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol 166 (1992) 962-968
31. Nagasaka J., Tsuji M., Takeda H., and Matsumiya T. Role of endothelin receptor subtypes in the behavioral effects of the intracerebroventricular administration of endothelin-1 in conscious rats. Pharmacol Biochem Behav 64 (1999) 171-176
32. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-22.
33. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
34. Roberts J.M., and Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 357 (2001) 53-56
35. Conrad K.P., and Benyo D.F. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 37 (1997) 240-249
36. Vezzani A. Inflammation and epilepsy. Epilepsy Curr 5 (2005) 1-6
37. Vezzani A., Moneta D., Richichi C., et al. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 43 Suppl. 5 (2002) 30-35
38. Vezzani A., Conti M., De Luigi A., et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 19 (1999) 5054-5065
39. Vezzani A., Moneta D., Conti M., et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 97 (2000) 11534-11539
40. Kupferminc M.J., Peaceman A.M., Wigton T.R., Rehnberg K.A., and Socol M.L. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 170 (1994) 1752-1757 [discussion 1757-9]
41. Hallenbeck J.M. The many faces of tumor necrosis factor in stroke. Nat Med 8 (2002) 1363-1368
42. Baram T.Z., and Schultz L. Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res 61 (1991) 97-101
43. Xiong Z.Q., Qian W., Suzuki K., and McNamara J.O. Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. J Neurosci 23 (2003) 955-960
44. Roes E.M., Sweep C.G., Thomas C.M., et al. Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia. Am J Obstet Gynecol 187 (2002) 1019-1025
45. Yepes M., and Lawrence D.A. New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system. Exp Biol Med (Maywood) 229 (2004) 1097-1104
46. Nicole O., Docagne F., Ali C., et al. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7 (2001) 59-64
47. Yepes M., Sandkvist M., Coleman T.A., et al. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent. J Clin Invest 109 (2002) 1571-1578
48. Benarroch E.E. Tissue plasminogen activator: beyond thrombolysis. Neurology 69 (2007) 799-802
49. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 5 (2003) 600-602
50. Goodlin R.C. Expanded toxemia syndrome or gestosis. Am J Obstet Gynecol 154 (1986) 1227-1233